+------------------------------------------------------------------------------+
China Services Gauge Joins Manufacturing in Showing Slowdown (1) 2014-11-03 02:43:45.683 GMT
(Updates with HSBC PMI report in seventh paragraph.)
By Bloomberg News Nov. 3 (Bloomberg) -- A gauge of China’s services industry fell to a nine-month low in October, joining manufacturing in signaling a broadening economic slowdown. The government’s non-manufacturing Purchasing Managers’ Index fell to 53.8 last month from 54 in September. The official manufacturing PMI released Nov. 1 was at 50.8 in October compared with September’s 51.1. Readings above 50 for both measures indicate expansion. The pullback in services and manufacturing will test the government’s determination to refrain from increased stimulus as the world’s second-largest economy heads toward the slowest full-year growth since 1990. The economy expanded 7.3 percent in the third quarter, the weakest pace in more than five years. “The momentum looks weak,” said Hua Changchun, a China economist at Nomura Holdings Inc. in Hong Kong. The effectiveness of the government’s targeted measures to boost the economy has waned, Hua said. The non-manufacturing PMI report showed a measure of expectations dropped 1 point from a month earlier, while readings of new orders, input prices and prices charged all increased from September, the report showed. Both PMI gauges are released by the National Bureau of Statistics and China Federation of Logistics and Purchasing in Beijing. A separate PMI index from HSBC Holdings Plc and Markit Economics for October was at 50.4, unchanged from the preliminary figure and up from September’s final reading of 50.2. Higher new-export business was attributed to stronger demand from customers across key export markets, suggesting robust external demand is helping underpin the economy.
Economic Headwinds
The official PMI report released Nov. 1 showed growth slowed from September for output, new orders, new export orders, stockpiles and expectations. The economy “still faces some headwinds” although a downward trend is unlikely after the government implemented policies to stabilize growth in the third quarter, the statement said. “The biggest drivers of growth such as fixed-asset investment are still slowing,” Shen Jianguang, chief Asia economist at Mizuho Securities Asia Ltd., said after the official manufacturing PMI. “Heavy industries like steel and coal are contracting on lower prices, and the negative impact of the weak property market is becoming more pronounced.” China will “stabilize” property-related consumption and make it easier for people to access mandatory housing savings, according to a government statement citing a State Council meeting chaired by Premier Li Keqiang. This came after the central bank on Sept. 30 relaxed mortgage rules for homebuyers who have paid off existing loans. China will support consumption in six areas, including property, e-commerce, environment-friendly products and tourism, according to the statement.
For Related News and Information: Top Stories:TOP<GO> China Backs Growth in Housing Again as Slowdown Prompts U-Turn NSN NE8MIW6S972H <GO> China Factory Gauge Rises as Workers Weather Slowdown: Economy NSN NDVMYO6S972G <GO> China’s GDP Growth Bolsters Case for Stimulus Refrain: Economy NSN NDSFCQ6JTSEN <GO>
--With assistance from Feiwen Rong in Beijing.
To contact Bloomberg News staff for this story: Xiaoqing Pi in Beijing at +86-10-6649-7570 or xpi1@bloomberg.net To contact the editors responsible for this story: Malcolm Scott at +852-2293-1975 or mscott23@bloomberg.net James Mayger
Publicis Groupe Said in Talks to Acquire Sapient
French Advertising Giant Seeks to Bounce Back From Failed Merger with Omnicom Group
Publicis Groupe SA is in talks to buy Sapient Corp. as the French advertising giant seeks to speed up its transformation into a digital-technology company and bounce back from its failed attempt to merge with Omnicom Group Inc.
A deal to buy Sapient, a U.S.-based digital-advertising specialist with a market capitalization of around $2.5 billion, could be announced as soon as Monday, people familiar with the matter said.
It is still possible the talks could fall apart at the last minute.
Spokeswomen for Publicis and Sapient didn’t return calls seeking comment.
Publicis, the world’s third-largest ad company, this Friday is scheduled to present to investors its plans for boosting growth from digital advertising, which is becoming increasingly dominated by data and technology. Chief Executive Maurice Lévy has been busy coming up with a new plan ever since the collapse of the planned merger with U.S. rival Omnicom in May and as sales growth has been slowing in recent quarters.
One rationale behind the Publicis-Omnicom merger was to give both companies more scale to better compete and negotiate with Web giants such as Google Inc. and Facebook Inc. Since the merger was called off amid internal power struggles, analysts have been wondering how Publicis and Omnicom would compete independently.
With Sapient, Publicis adds a more digital-focus to its wide array of agencies that runs from traditional creative firms such as Saatchi & Saatchi and Leo Burnett to digital shops such as Digitas.
Sapient, one of a slew of highflying tech consulting firms in the dot com boom, has gone through many transformations over the past decade. Once a tech consulting player that helped marketers build websites, the company has expanded its offering through acquisitions. Last year, Sapient bought mPhasize a company that helps marketers use data to help them figure out where to spend their ad dollars. In 2009, it became more of a traditional ad player when it bought Nitro Group LLC, a traditional ad agency based in New York.
The firm is one of the last big independent digital agencies. Its clients include Mondelez International Inc., Coca-Cola Co. and Target Corp. The company had revenue of $1.26 billion last year.
A deal to buy Sapient would be Publicis’ first major acquisition in the digital arena since it bought Amsterdam-based LBi for $500 million in 2012. Publicis has a track record of spending big to buy up digital ad firms. In 2011, the French company bought U.S. digital-ad firm Rosetta Marketing for $575 million, and in 2007, it bought Boston-based Digitas for $1.3 billion.
The big push into digital comes as the pressure builds on advertising holding companies’ business model.
Agencies are facing increasing competition from a new crop of digital, data analytics and tech companies that claim they can do some of the tasks that have long been handled by agencies.
Even the onetime cozy relationship between marketers and creative agencies is under threat. Years ago, brands would have an agency-of-record relationship with one creative firm, but nowadays, more marketers are working with many different companies to develop creative ad content, which they need more of so they can keep up with the rise of social media.
Marketers have continued to squeeze cost out of ad firms by pressuring them to reduce the fees they charge. Companies such as Procter & Gamble Co., Mondelez and Anheuser-Busch InBev are among the big marketers that have moved toward pushing back the date that they have to play suppliers, including agencies.
Besides such issues, Publicis has been suffering from the aftermath of its attempt to merge with Omnicom. Sales growth has underperformed major rivals in the past quarters, which Publicis has blamed in large part on the distraction caused by the plans to pull off the big merger.
Publicis has also faced some revenue shortfalls at some key digital agencies such as Razorfish, where some big clients cut back on spending and key managers left.
Mr. Lévy—who recently agreed to stay in his CEO role longer than expected—has been working on an internal strategy review over the summer aimed at getting the company’s priorities back on track and speeding up its transformation into a digital company. The company in September also announced a series of management changes in a bid to get its teams working more effectively.
Hinting that there would be more deals coming, Mr. Lévy has said in recent months that he wanted Publicis to resemble more of an "Internet company."
"I think that people have not even seen the tip of the iceberg," Mr. Lévy told analysts in a conference call on third-quarter revenue last week, referring to the rapid transformation technology is bringing to the ad industry. "What is boiling down in t
2014-11-03 00:00:01.2 GMT
(For a Real M&A column news alert: SALT REALMNA <GO>.)
By Brooke Sutherland
Nov. 3 (Bloomberg) -- Evonik Industries AG may find it’s
tough to be a buyer in a seller’s market.
Royal DSM NV, Clariant AG and Croda International Plc have
made the German chemical maker’s short list as it seeks a large
European takeover target, according to people familiar with the
matter. Despite the companies’ lackluster returns this year, all
three still trade at a premium to the median profit multiple
paid for recent chemicals deals, according to data compiled by
Bloomberg.
European chemical companies have gotten more expensive over
the last three years, with an index of 25 companies including
Clariant, Croda and DSM reaching a peak valuation in July.
Symrise AG, which makes flavors and fragrances, is even more
expensive than the other targets, but would best fill the holes
in Evonik’s portfolio, according to DZ Bank AG. If the valuation
is too high, Clariant looks better than DSM because it’s half
the size.
“It’s a good time for the sellers, but it’s not a good
time for the buyers,” Peter Spengler, a Frankfurt-based analyst
at DZ Bank, said in a phone interview. “It’s not peak valuation
now but it’s a little bit below peak.”
Evonik’s Revamp
Evonik is looking for deals that will help it expand into
less volatile, higher-margin businesses, after sales declined.
The company has been reorganizing to decrease sensitivity to
price swings.
Chief Financial Officer Ute Wolf said last month that the
Essen-based company has the resources to execute a “sizeable”
acquisition. Evonik will focus on deals that strengthen the
consumer, health and nutrition unit and the resource efficiency
division.
The maker of cosmetic ingredients is talking with advisers
about a potential deal with DSM and also evaluating companies
such as Croda and Clariant, according to people familiar with
the matter, who asked not to be identified because discussions
are private.
Even before accounting for a takeover premium, those three
targets are already expensive by some measures. They trade at an
average of 10.2 times earnings before interest, taxes,
depreciation and amortization. In the last five years, buyers
paid a median profit multiple of 8.8 for chemical companies in
deals larger than $1 billion, according to data compiled by
Bloomberg.
Clariant on Top
Among those three, Clariant “would be the best potential
target,” based on its size and what Evonik can afford, said
Spengler of DZ Bank. Clariant has the lowest profit multiple of
the three, trading at 9.1 times its Ebitda in the last year.
Clariant Chief Executive Officer Hariolf Kottmann has
revamped the company, which makes petrochemical catalysts and
shampoo ingredients, to improve profitability and focus more on
less-volatile specialty chemicals. Analysts project that net
income will rise next year to the highest level in more than a
decade and that free cash flow will jump to more than $400
million by 2016, according to data compiled by Bloomberg.
“Clariant really stands out,” Brian Hennessey, a fund
manager at Purchase, New York-based Alpine Woods Capital
Investors LLC, which oversees about $4.5 billion including
Clariant shares, said in a phone interview. The $5.8 billion
company will have “good free cash flow generation and a product
portfolio that’s defensively oriented but with still decent
growth.”
Symrise, which makes perfume oils and flavors for ice cream
and snack food, would be an ideal supplement to Evonik, said
Spengler of DZ Bank. Its operating margin, at 16 percent, is
about double Evonik’s. The only problem is Symrise is even more
expensive, with an Ebitda multiple of 15.
Go Small
Evonik will probably focus on niche acquisitions instead,
said Ronald Koehler, a Frankfurt-based analyst at MainFirst Bank
AG. That makes more strategic sense than a transformational
takeover of a conglomerate such as DSM, he said. Those kinds of
deals may also be cheaper.
“It’s potentially not the best time, but the industry is
thinking differently than portfolio managers,” Koehler said in
a phone interview. “They’re buying when they have cash and they
definitely right now have cash. At the end of the day, it’s also
availability, which is necessary.”
For Related News and Information:
Evonik Seeks Growth Through Acquisitions Amid Investment Cut
NSN NCTCM66KLVR6 <GO>
Evonik Said Exploring DSM Takeover Amid Chemical Deals Hunt
NSN NE9K1V6K50Y6 <GO>
Clariant Revamp Makes Chemical Maker Target for BASF: Real M&A
NSN NCSFSC6JTSEG <GO>
Top Deal Stories: DTOP <GO>
M&A Search: MA <GO>
To contact the reporter on this story:
Brooke Sutherland in New York at +1-212-617-0448 or
bsutherland7@bloomberg.net
To contact the editors responsible for this story:
Beth Williams at +1-212-617-2307 or
bewilliams@bloomberg.net
Whitney Kisling